(RTTNews) - Johnson & Johnson (JNJ), Thursday announced results from additional analyses of the Phase 2 DAHLIAS study, evaluating the effects of Nipocalimab in participants with primary Sjogren's ...
Zacks.com on MSN4h
Why Is Johnson & Johnson (JNJ) Down 6.7% Since Last Earnings Report?Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
"Latino male Trump voter told CNN mass deportation won't extend to law-abiding workers. 'That wouldn’t be fair. They need to ...
Renaissance Technologies took new stakes in Micron Technology (NASDAQ:MU), Eli Lilly (NYSE:LLY), and Cisco Systems ...
Johnson & Johnson (NYSE: JNJ) today announced results from additional analyses of the Phase 2 DAHLIAS study highlighting improvement in key measures of disease activity and significant IgG reduction ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Try Now>> See today’s best-performing stocks on TipRanks >> Read More on JNJ: Johnson & Johnson NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Historically an active player in the M&A space, Radnor-based Avantor has not found itself so busy in that realm during the ...
Get-Up 3 will feature Brittany Howard of Alabama Shakes, Mike Cooley of Drive-by Truckers, Lee Bains and more.
Shares of vaccine makers closed lower Thursday amid reports that President-elect Donald Trump was set to nominate vaccine ...
The stock is currently at ~$190. There was a ~10% further increase over the last two quarters. Johnson & Johnson (JNJ): JNJ ...
Trump may appoint Robert F. Kennedy Jr. as HHS Secretary, stirring mixed reactions. Kennedy's views on vaccines could reshape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback